This bill amends the Oklahoma Medical Marijuana and Patient Protection Act by establishing new requirements for medical marijuana testing laboratories. It mandates that final harvest and production batch samples be tested for specific pesticide analytes, with allowable thresholds set for each analyte in parts per million. A total of 72 pesticide analytes are listed, including substances like Abamectin, Azoxystrobin, and Imidacloprid, to ensure the safety and quality of medical marijuana products. The bill also outlines the licensure and inspection process for laboratories, requiring initial inspections and up to two subsequent inspections each year, as well as accreditation from an approved body within one year of receiving their initial license.

Furthermore, the bill introduces penalties for violations related to testing standards, including fines and potential license revocation for repeated infractions. It emphasizes the need for accurate record-keeping, thorough contaminant testing, and transparency in laboratory processes. The effective date for these changes is set for June 1, 2024, with the aim of enhancing the integrity of medical marijuana testing in Oklahoma to better protect patients and consumers.

Statutes affected:
Introduced: 63-427.17